Literature DB >> 27282253

Commentary on: 'Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia'.

C A Schiffer1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27282253     DOI： 10.1038/leu.2016.141

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Problems with up-front randomization in clinical trials.

Authors:  Keith Wheatley; Robert K Hills; Alan K Burnett
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

2.  Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.

Authors:  T Büchner; U O Krug; R Peter Gale; A Heinecke; M C Sauerland; C Haferlach; S Schnittger; T Haferlach; C Müller-Tidow; M Stelljes; R M Mesters; H L Serve; J Braess; K Spiekermann; P Staib; A Grüneisen; A Reichle; L Balleisen; H Eimermacher; A Giagounidis; H Rasche; E Lengfelder; D Görlich; A Faldum; W Köpcke; R Hehlmann; B J Wörmann; W E Berdel; W Hiddemann
Journal:  Leukemia       Date:  2016-03-11       Impact factor: 11.528

3.  Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.

Authors:  W Plunkett; J O Liliemark; T M Adams; B Nowak; E Estey; H Kantarjian; M J Keating
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

4.  Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial.

Authors:  Alan K Burnett; Nigel H Russell; Robert K Hills; Ann E Hunter; Lars Kjeldsen; John Yin; Brenda E S Gibson; Keith Wheatley; Donald Milligan
Journal:  J Clin Oncol       Date:  2013-08-12       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.